During the past decade, Krajska Nemocnice T. Bati a.s. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krajska Nemocnice T. Bati a.s." #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "The Institute of Molecular and Translational Medicine, Czech Republic" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska Nemocnice T. Bati a.s." #1 collaborator was "Tomas Bata Hospital, Czech Republic" with 3 trials as a collaborator, "General University Hospital, Prague" with 2 trials as a collaborator, "Hospital Novy Jicin" with 2 trials as a collaborator, "University Hospital Ostrava" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Krajska Nemocnice T. Bati a.s." are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Circulating Tumor Cell" (2 trials), "Colorectal Cancer" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Krajska Nemocnice T. Bati a.s." in a lesser frequency.

Most popular intervention types in "Krajska Nemocnice T. Bati a.s." are "Drug" (27 trials), "Other" (4 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (3 trials), "Mirikizumab" (3 trials), "Morphine" (3 trials) and "Degarelix" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krajska Nemocnice T. Bati a.s." are 26 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Krajska Nemocnice T. Bati a.s.". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Krajska Nemocnice T. Bati a.s., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Krajska Nemocnice T. Bati a.s., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".